openPR Logo
Press release

Gabapentin Market is Projected to Expand at a CAGR of 4.37% to reach USD 3,036.38 Million by 2032

05-02-2024 11:58 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Gabapentin Market

Gabapentin Market

๐€๐œ๐œ๐จ๐ซ๐๐ข๐ง๐  ๐ญ๐จ ๐ญ๐ก๐ž ๐ซ๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ญ๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ ๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ,๐Ÿ—๐Ÿ–๐Ÿ.๐Ÿ”๐ŸŽ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ ๐š๐ง๐ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ‘,๐ŸŽ๐Ÿ‘๐Ÿ”.๐Ÿ‘๐Ÿ– ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐š๐ญ ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ’.๐Ÿ‘๐Ÿ•% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐.

Gabapentin is an anticonvulsant medication primarily used in the treatment of seizures and other neuropathic conditions. Along with controlling seizures and relieving nerve pain, gabapentin finds applications in the treatment of moderate-to-severe primary restless leg syndrome. It works by reducing the excitability of the brain's nervous cells, which are responsible for seizures and transmission of pain signals. Gabapentin is available in several forms, including tablets, oral solutions, and capsules. It's taken with or without food, as directed by the healthcare provider.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ญ๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž:
https://www.polarismarketresearch.com/industry-analysis/gabapentin-market/request-for-sample

๐“๐จ๐ฉ ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ

The gabapentin market is characterized by fragmentation. Several players are focusing on strategies such as mergers, acquisitions, and collaborations to garner a larger industry share. Some of the top players operating in the industry include:

โ€ข Pfizer Inc.
โ€ข Teva Pharmaceutical Industries Ltd.
โ€ข Sun Pharmaceutical Industries Ltd. Aurobindo Pharma Ltd.
โ€ข Lupin Limited
โ€ข Mylan N.V.
โ€ข Cipla Limited
โ€ข Hikma Pharmaceuticals PLC
โ€ข Arbor Pharmaceuticals Inc.
โ€ข Zydus Cadila Healthcare Limited
โ€ข Glenmark Pharmaceuticals Ltd.
โ€ข Apotex Inc.
โ€ข Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd.
โ€ข Wockhardt Ltd

๐Š๐ž๐ฒ ๐’๐ญ๐š๐ญ๐ฌ

โ€ข The global gabapentin market was valued at USD 1,981.60 million in 2022.
โ€ข The industry is projected to grow at a compound annual growth rate of 4.37% during the forecast period from 2023 to 2032.
โ€ข The market is anticipated to reach USD 3,036.38 million by 2032.

๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐“๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:
https://www.polarismarketresearch.com/buy/2178/2

๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ

The growing incidence of neuropathic pain and seizures is one of the key factors propelling the market forward. With the aging population, the prevalence of chronic pain and neurological conditions is expected to rise. This, in turn, is anticipated to fuel the demand for medications such as gabapentin.

The rising usage of gabapentin for off-label indications like insomnia, bipolar disorder, and anxiety is another factor propelling the industry forward. While the FDA hasn't specifically approved the drug for the treatment of these conditions, there is rising evidence that supports their effectiveness in treating these conditions.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

โ€ข Gabapentin is highly prescribed and one of the top 30 prescription medications in the United States. The demand for gabapentin is projected to rise owing to the increased prevalence of chronic pain and neurological disorders.
โ€ข The Asia Pacific region is anticipated to witness a significant rise in the demand for gabapentin owing to the rising prevalence of various neurological disorders. Additionally, the increased healthcare spending is expected to drive the demand for medication in the region.

๐๐ซ๐จ๐ฐ๐ฌ๐ž ๐Œ๐จ๐ซ๐ž ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ฌ:
https://www.polarismarketresearch.com/industry-analysis/gabapentin-market

๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง๐ฌ:

๐„๐ฉ๐ข๐ฅ๐ž๐ฉ๐ฌ๐ฒ:Gabapentin is primarily indicated for the treatment of epilepsy as an adjunctive therapy to control seizures in patients with partial seizures with or without secondary generalization.

๐๐ž๐ฎ๐ซ๐จ๐ฉ๐š๐ญ๐ก๐ข๐œ ๐๐š๐ข๐ง:Gabapentin is widely used for the management of neuropathic pain associated with conditions such as diabetic neuropathy, postherpetic neuralgia, spinal cord injury, and trigeminal neuralgia.

๐‘๐ž๐ฌ๐ญ๐ฅ๐ž๐ฌ๐ฌ ๐‹๐ž๐ ๐ฌ ๐’๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž:Gabapentin may be prescribed for the treatment of restless legs syndrome, a neurological disorder characterized by uncomfortable sensations in the legs and an irresistible urge to move them.

๐Ž๐Ÿ๐Ÿ-๐‹๐š๐›๐ž๐ฅ ๐”๐ฌ๐ž:Gabapentin is prescribed off-label for conditions such as fibromyalgia, anxiety disorders, migraine prophylaxis, and alcohol withdrawal syndrome, among others.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

๐†๐ฅ๐จ๐›๐š๐ฅ ๐†๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง, ๐ƒ๐จ๐ฌ๐š๐ ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ—-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)
โ€ข Capsule
โ€ข Tablet

๐†๐ฅ๐จ๐›๐š๐ฅ ๐†๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง, ๐“๐ฒ๐ฉ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ—-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)
โ€ข Branded
โ€ข Generic

๐†๐ฅ๐จ๐›๐š๐ฅ ๐†๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง, ๐Œ๐ž๐ญ๐ก๐จ๐ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ—-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)
โ€ข Column-based
โ€ข Magnetic Beads
โ€ข Reagent-based
โ€ข Others

๐†๐ฅ๐จ๐›๐š๐ฅ ๐†๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง, ๐€๐ฉ๐ฉ๐ฅ๐ข๐œ๐š๐ญ๐ข๐จ๐ง ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค (๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐”๐’๐ƒ ๐Œ๐ข๐ฅ๐ฅ๐ข๐จ๐ง, ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ—-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ)
โ€ข Neuropathic Pain
โ€ข Epilepsy
โ€ข Restless Legs Syndrome
โ€ข Others

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

๐„-๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/e-pharma-market

๐„๐ซ๐ž๐œ๐ญ๐ข๐ฅ๐ž ๐ƒ๐ฒ๐ฌ๐Ÿ๐ฎ๐ง๐œ๐ญ๐ข๐จ๐ง ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market

๐€๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/global-autoimmune-disease-diagnostics-market

๐๐ซ๐ฎ๐ซ๐ข๐ญ๐ฎ๐ฌ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ž๐ฎ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ: https://www.polarismarketresearch.com/industry-analysis/global-pruritus-therapeutics-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gabapentin Market is Projected to Expand at a CAGR of 4.37% to reach USD 3,036.38 Million by 2032 here

News-ID: 3482494 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Beta-Glucan Market is anticipated to grow from USD 666.60 million in 2024 to USD 1262.91 million by 2032
05-24-2024 | Chemicals & Materials
Polaris Market Research & Consulting
Beta-Glucan Market is anticipated to grow from USD 666.60 million in 2024 to USD โ€ฆ
The global beta-glucan market is expected to reach USD 1262.91 million by 2032, growing at an 8.3% CAGR from 2024 to 2032. It was valued at USD 615.68 million in 2023. The market is experiencing significant growth and is expected to continue expanding in the coming years. Beta-glucans are dissolvable fibers that emanate from the cell walls of bacteria, yeast, fungi, and some plants. They are helpful in lessening the probabilityโ€ฆ
Methanol Market is anticipated to grow from US$ 32.47 billion in 2024 to US$ 47.21 billion by 2032, at a CAGR of 4.8% from 2024 to 2032 | PMR
05-24-2024 | Chemicals & Materials
Polaris Market Research & Consulting
Methanol Market is anticipated to grow from US$ 32.47 billion in 2024 to US$ 47. โ€ฆ
The increased production of other basic chemicals used in end-use products and fuels is the primary factor driving the growth of the industry. Besides, the advent of new applications of methanol, which include fuel blending, ether production, and light olefins, is supporting the expansion of the market. ๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ฆ๐ž๐ญ๐ก๐š๐ง๐จ๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ข๐ณ๐ž ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ‘๐Ÿ.๐ŸŽ๐Ÿ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘. ๐“๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ฉ๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ ๐ซ๐จ๐ฐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ’๐Ÿ•.๐Ÿ๐Ÿ ๐›๐ข๐ฅ๐ฅ๐ข๐จ๐งโ€ฆ
Hydrogen Peroxide Market Predicted to Grow at 4.8% CAGR, Reaching USD 5145.43 Million by 2032 | Data by PMR
05-24-2024 | Chemicals & Materials
Polaris Market Research & Consulting
Hydrogen Peroxide Market Predicted to Grow at 4.8% CAGR, Reaching USD 5145.43 Mi โ€ฆ
According to Polaris Market Research's study, the hydrogen peroxide market is expected to grow at a CAGR of 4.8% over the estimated period. The industry value is expected to grow from USD 3380.00 million in 2023 to USD 5145.43 million in 2032. The industry's growth is being fuelled by its discharge-free and sustainable attributes. Thus, customers growingly opt for to utilize chemicals for several contamination regulation and water ministration solicitation. ๐€๐œ๐œ๐ž๐ฌ๐ฌโ€ฆ
Printing Inks Market is anticipated to grow from USD 22.19 billion in 2024 to USD 39.66 billion by 2032
05-24-2024 | Chemicals & Materials
Polaris Market Research & Consulting
Printing Inks Market is anticipated to grow from USD 22.19 billion in 2024 to US โ€ฆ
The global printing inks market was valued at USD 20.65 billion in 2023 and is expected to grow to USD 39.66 billion by 2032. The market is expected to expand at a CAGR of 7.5% during the forecast period from 2024 to 2032. Various factors propelling the demand for the printing ink industry include: The printing ink industry has witnessed significant growth, particularly in the flexible packaging segment, over the pastโ€ฆ

All 5 Releases


More Releases for Gabapentin

05-26-2022 | Health & Medicine
A2Z Market Research
Growth Analysis & Projection of Gabapentin Market
The Gabapentin Market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. The report presents the overview of the market with the production of the cost, dispatch, application, use volume andโ€ฆ
07-03-2020 | Advertising, Media Consulting, โ€ฆ
LP Information
Gabapentin Enacarbil Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Acenocoumarol market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Acenocoumarolmarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Acenocoumarolmarket, market definition, overview, industry opportunities and trends, investment strategy with forcefulโ€ฆ
07-03-2020 | Advertising, Media Consulting, โ€ฆ
LP Information
Gabapentin Enacarbil Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Gabapentin Enacarbil market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Gabapentin Enacarbilmarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Gabapentin Enacarbilmarket, market definition, overview, industry opportunities and trends, investmentโ€ฆ
10-07-2019 | Health & Medicine
QY Research, Inc.ย 
Gabapentin Market | Global Industry Analysis | 2019 - 2025 | Qy Research
The global Gabapentin market is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data on the global Gabapentin market. The report equips players with useful information and suggests result-oriented ideas to gain a competitive edge in the global Gabapentinโ€ฆ
01-21-2019 | Business, Economy, Finances, B โ€ฆ
Research 2 Reports
Gabapentin Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-pharmaceuticals/gabapentin-market-2/71834 The global market size of Gabapentin is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, majorโ€ฆ
01-08-2018 | Health & Medicine
(MRE) Report
Gabapentin Sales Market - Global Industry Analysis, Size, Share, Growth By 2022
Florida, January 08, 2018: The global gabapentin sales market is segmented on the lines of its technology, treatment, application and regional. Based on product type segmentation it covers tablets, capsule; and based on end users it covers nerve pain, restless legs syndrome, seizures. The global gabapentin sales marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market isโ€ฆ